PDK1 and cancer: Constitutive activation of PI3-K/PDK-1/AKT signalling mediates the survival signals and confers resistance to apoptosis induced by anticancer cytotoxic agents in human cancer cells (Page et al, 2000; Nesterov et al, 2001; Clark et al, 2002).